Page 45 - TACC2017_program_reduced-size_Neat
P. 45
Athyrium Capital Management
Investor type: Asset Manager | Year founded: 2008
Athyrium Capital Management, LP is a specialized asset Contact Primary contact
management company formed in 2008 to focus on investment 530 Fifth Avenue Derek Lee
opportunities in the global healthcare sector. As of December 31 , 25th Floor Senior Advisor
2016, Athyrium had over $3.2 billion of assets under management. New York, NY 10036 [email protected]
The Athyrium team has investment experience in the healthcare United States
sector across a wide range of asset classes including public equity, +1 (212) 402-6925
private equity, fixed income, royalties, and other structured
securities. Athyrium invests across all healthcare verticals including
biopharma, medical devices and products, and healthcare focused
services. The team partners with management teams to implement
creative financing solutions to companies’ capital needs.
General statistics
Assets under management Total private equity investments Preferred Investment amount
$3.2B 38 $25M-$150M
Recently closed investments Most recent closed fund
Name Deal type Deal date Athyrium Opportunities Fund II
Interamerican Medical Center Debt/Equity Investment Feb-2017 Type: Direct Lending
Highland Acquisition Holdings, LLC Debt Investment Nov-2016 Size: $1.2B
Pharmaceutics International Debt/Equity Investment Aug-2016
Medicrea Debt Investment Aug-2016 Vintage: 2015
Arbor Pharmaceuticals Secondary Transaction Jul-2016
All investments by industry
Healthcare 80.0%
Data sourced from the PitchBook Platform, the financial information technology trusted by leading investors, companies and advisors.
Investor type: Asset Manager | Year founded: 2008
Athyrium Capital Management, LP is a specialized asset Contact Primary contact
management company formed in 2008 to focus on investment 530 Fifth Avenue Derek Lee
opportunities in the global healthcare sector. As of December 31 , 25th Floor Senior Advisor
2016, Athyrium had over $3.2 billion of assets under management. New York, NY 10036 [email protected]
The Athyrium team has investment experience in the healthcare United States
sector across a wide range of asset classes including public equity, +1 (212) 402-6925
private equity, fixed income, royalties, and other structured
securities. Athyrium invests across all healthcare verticals including
biopharma, medical devices and products, and healthcare focused
services. The team partners with management teams to implement
creative financing solutions to companies’ capital needs.
General statistics
Assets under management Total private equity investments Preferred Investment amount
$3.2B 38 $25M-$150M
Recently closed investments Most recent closed fund
Name Deal type Deal date Athyrium Opportunities Fund II
Interamerican Medical Center Debt/Equity Investment Feb-2017 Type: Direct Lending
Highland Acquisition Holdings, LLC Debt Investment Nov-2016 Size: $1.2B
Pharmaceutics International Debt/Equity Investment Aug-2016
Medicrea Debt Investment Aug-2016 Vintage: 2015
Arbor Pharmaceuticals Secondary Transaction Jul-2016
All investments by industry
Healthcare 80.0%
Data sourced from the PitchBook Platform, the financial information technology trusted by leading investors, companies and advisors.
